Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Advenchen Laboratories, LLC logo — Pioneering novel therapies with promising small molecule kin...

Advenchen Laboratories, LLC

Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter future in cancer treatment.

Founded 2003 6 employees Venture round Total: $4.48M Biotechnology, Health Care +1

General Information

Company Name Advenchen Laboratories, LLC
Founded Year 2003
Founders / Decision Makers
Team member
Employees 6
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Advenchen Laboratories, LLC. To contact Advenchen Laboratories, LLC, visit advenchen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Advenchen Laboratories, LLC compare?

A PDF of Advenchen Laboratories, LLC and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Advenchen Laboratories, LLC soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Advenchen Laboratories, LLC

Advenchen Laboratories is a boutique pharmaceutical company founded in 2003, specializing in small molecule cancer drug discovery programs. The company's focus on identifying small molecule kinase inhibitors, particularly protein tyrosine kinase (PTK) inhibitors, marks a promising approach to cancer treatment. Their proprietary drug development pipeline has demonstrated significant anti-tumor activities and therapeutic benefits across various targets. Venture Round investment of $4.48M was secured by Advenchen Laboratories on 20 May 2010. The company's dedication to pioneering novel therapies with these promising small molecule kinase inhibitors sets a compelling narrative for potential investors. The development of breakthrough therapies for cancer patients may yield opportunities for substantial returns on investment, especially within the Biotechnology and Pharmaceutical industries. The sloganeering of "Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter future in cancer treatment" encapsulates their mission to revolutionize cancer therapy. This distinctive approach positions Advenchen Laboratories as an intriguing opportunity for venture capitalists seeking to support groundbreaking advancements in the fight against cancer.

Business keywords: pharmaceutical research, small molecule drugs, kinase inhibitors, cancer treatment, protein tyrosine kinase, drug discovery, anti-tumor activities, therapeutic benefits, proprietary drug development, novel therapies

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $4.48M -
20 May 2010

Advenchen Laboratories, LLC Alternatives & Competitors

View All Alternatives
Advenchen Laboratories, LLC vs
DAAN Biotherapeutics
DAAN Biotherapeutics

Innovative treatments for cancer: empowering patients with advanced research in cell therapies, anti...

Seed
Biotechnology, Health Care
Advenchen Laboratories, LLC vs
Tempest Therapeutics
Tempest Therapeutics

Pioneering the future of cancer treatment with innovative small molecule therapeutics that enhance a...

Post-IPO Equity
11-50 employees
Biotechnology, Health Care
Advenchen Laboratories, LLC vs
Altheos
Altheos

Pioneering novel treatments with promising small molecule drugs for glaucoma, supported by significa...

Series A
Biotechnology, Health Care
Also compare with: Advenchen Laboratories, LLC vs Ascentage Pharma Ascentage Pharma Advenchen Laboratories, LLC vs Ambit Ambit View all alternatives

FAQ About Advenchen Laboratories, LLC

Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter future in cancer treatment.
Advenchen Laboratories, LLC was founded in 2003.
Advenchen Laboratories, LLC operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on pharmaceutical research, small molecule drugs, kinase inhibitors and cancer treatment.
Advenchen Laboratories, LLC has approximately 6 employees.
Advenchen Laboratories, LLC has completed 1 funding round, raising a total of $4.48M. The latest funding stage is Venture round.
Top alternatives and competitors to Advenchen Laboratories, LLC include DAAN Biotherapeutics, Tempest Therapeutics, Altheos, MACROPHAGE PHARMA LIMITED, Sibylla Biotech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Advenchen Laboratories, LLC and DAAN Biotherapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Advenchen Laboratories, LLC, https://bouncewatch.com/company/advenchen-laboratories, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes